In practice, we found that the anionic Lipo-ORG was able to suppress tumour growth, metastasis and extend survival in the B16-OVA tumour model, in which the efficacy is further amplified by synergizing with PD-L1 blockade. The gene discussed is CD274; the disease is neoplasm.